Serina Therapeutics Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Serina Therapeutics stock ranges from a low of $11 to a high of $15. The average analyst price target of $13 forecasts a 142.31% increase in the stock price over the next year.

Price Target: $13.00 (+142.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$13	$15	$15
Change	+105.03%	+142.31%	+179.59%	+179.59%

* Price targets were last updated on Jul 14, 2025.

Analyst Ratings

The average analyst rating for Serina Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25
Strong Buy	1	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+179.59%	Jul 14, 2025
Justin Walsh Jones Trading	Jones Trading	Strong Buy Initiates $11	Strong Buy	Initiates	$11	+105.03%	Mar 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 56.00K

Revenue Next Year

n/a

EPS This Year

-1.97

from -1.51

EPS Next Year

-1.55

from -1.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.46M	591.50K	3.15M	56.00K	-	-	-
Revenue Growth	-	-82.93%	433.05%	-98.22%	-	-	-
EPS	-0.59	-1.25	0.72	-1.51	-1.97	-1.55	-1.29
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	2	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.05	-1.61	-1.34
Avg	-1.97	-1.55	-1.29
Low	-1.91	-1.50	-1.25

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.